Comparative In Vitro Activities of N -Formimidoyl Thienamycin and Moxalactam Against Nonfermentative Aerobic Gram-Negative Rods
Open Access
- 1 April 1982
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 21 (4), 673-675
- https://doi.org/10.1128/aac.21.4.673
Abstract
N-Formimidoyl thienamycin was the most active drug against strains of Pseudomonas aeruginosa with a 90% minimum inhibitory concentration of 1.25 μg/ml. With the exception of P. maltophilia, thienamycin was as active or more active than moxalactam against other species of pseudomonads and against other genera of nonfermenters.This publication has 18 references indexed in Scilit:
- N-formimidoyl thienamycin (MK0787): in vitro studyAntimicrobial Agents and Chemotherapy, 1981
- Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1980
- In Vitro Susceptibilities of Nonfermentative Gram-Negative Bacilli Other than Pseudomonas aeruginosa to 32 Antimicrobial AgentsClinical Infectious Diseases, 1980
- MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activitiesAntimicrobial Agents and Chemotherapy, 1980
- In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilliAntimicrobial Agents and Chemotherapy, 1980
- Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibioticsAntimicrobial Agents and Chemotherapy, 1980
- Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycinAntimicrobial Agents and Chemotherapy, 1980
- In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilliAntimicrobial Agents and Chemotherapy, 1979
- In Vitro Activity of LY127935Antimicrobial Agents and Chemotherapy, 1979
- LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activityAntimicrobial Agents and Chemotherapy, 1979